William Ashton - Dec 31, 2024 Form 3 Insider Report for Medicus Pharma Ltd. (MDCX)

Role
Director
Signature
/s/ James Quinlan, as Attorney-in-Fact, for William L. Ashton
Stock symbol
MDCX
Transactions as of
Dec 31, 2024
Transactions value $
$0
Form type
3
Date filed
12/31/2024, 04:01 PM
Previous filing
Apr 8, 2024
Next filing
Jul 24, 2025
SEC
View on sec.gov
This filing has been restated, see here for the amended filing

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding MDCX Common Shares, no par value ("Common Shares") 1.25K Dec 31, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding MDCX Stock Option (right to buy) Dec 31, 2024 Common Shares 25K $0.81 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option has vested and is exercisable as of the date hereof.
F2 Represents an exercise price of $1.16 Canadian dollars, converted to U.S. dollars at the daily average exchange rate of $1.00 to CAD$1.4379 reported by the Bank of Canada on December 30, 2024.

Remarks:

Exhibit List - Exhibit 24.1 - Power of Attorney